(Q40909255)

24 September 2017

1 reference

title

Antenatal screening for Down's syndrome. (English)

1 reference

24 September 2017

Ali McGuire

4

0 references

author name string

Nicholas J Wald

series ordinal

1

0 references

Anne Kennard

series ordinal

2

0 references

Allan Hackshaw

series ordinal

3

0 references

publication date

1 January 1997

1 reference

Journal of Medical Screening

24 September 2017

1 reference

24 September 2017

4

1 reference

24 September 2017

181-246

1 reference

24 September 2017

4

1 reference

Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida

24 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum screening for Down's syndrome in early pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Antenatal maternal serum screening for Down's syndrome: results of a demonstration project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Prenatal screening for Down's syndrome with use of maternal serum markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The extent of Down's syndrome screening in Britain in 1991

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First trimester serum screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Nuchal fluid accumulation in trisomy-21 detected by vaginosonography in first trimester.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Model-based screening by risk with application to Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum alpha-fetoprotein and fetal autosomal trisomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Second trimester screening for trisomy 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

A single chorionic gonadotropin assay for maternal serum screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Screening for Down's syndrome based on individual risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Comparison of multiple-marker screening with amniocentesis for the detection of fetal aneuploidy in women > or = 35 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Second-trimester dimeric inhibin-A in Down's syndrome screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Pregnancy associated plasma protein A in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Measurement of activity of urea resistant neutrophil alkaline phosphatase as an antenatal screening test for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Improved parameters for risk estimation in Down's syndrome screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum alpha-fetoprotein screening, maternal weight, and detection efficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The Effect of Weight Correction on Risk Calculations for Down's Syndrome Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Adjustment formulae for maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol to maternal weight and smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Effect of allowing for ethnic group in prenatal screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Refinements in managing maternal weight adjustment for interpreting prenatal screening results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum alpha-fetoprotein levels in diabetic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum alpha-fetoprotein in twin pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Multiple marker screening for Down syndrome in twin pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Letter: Racial differences in maternal serum-alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Recent advances in screening for neural tube defects and Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Racial differences in maternal serum human chorionic gonadotropin and unconjugated oestriol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Letter: Racial variation in maternal serum-alpha-fetoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Urinary multiple marker screening for Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Isolating fetal cells in maternal circulation for prenatal diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First trimester prenatal diagnosis of trisomy 21 in fetal cells from maternal blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum markers. Estimation of the risk of Down's syndrome: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotrophin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Can sonographers reliably identify anatomic features associated with Down syndrome in fetuses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Humeral Shortening in Second-Trimester Fetuses With Down Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Sonographic scoring index for prenatal detection of chromosomal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The association between an abnormal nuchal skin fold, trisomy 21, and ultrasound abnormalities identified during the second trimester of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The effect of fetal gender on the prediction of Down syndrome by means of maternal serum alpha-fetoprotein and ultrasonographic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: an alternative for high-risk patients who decline genetic amniocentesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Fetal femur length to detect trisomy 21. A reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The efficacy of fetal sonographic biometry in Down syndrome screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Femur length in the US prediction of trisomy 21 and other chromosomal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Femur length shortening in the detection of Down syndrome: is prenatal screening feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Comparison of humerus length with femur length in fetuses with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Fetal humeral length to detect Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Humerus and femur length in fetuses with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Ultrasonographic fetal iliac length measurement in the screening for Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Fetuses with Down syndrome have disproportionately shortened frontal lobe dimensions on ultrasonographic examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Routine radiographer screening for fetal abnormalities by ultrasound in an unselected low risk population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Improved ascertainment of cardiovascular malformations in infants with Down's syndrome, Atlanta, 1968 through 1989. Implications for the interpretation of increasing rates of cardiovascular malformations in surveillance systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Monitoring trends in prenatal diagnosis of Down's syndrome in England and Wales, 1989-92.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First-trimester maternal serum alpha-fetoprotein screening for chromosome defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First-trimester maternal serum unconjugated oestriol and alpha-fetoprotein in fetal Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First-trimester Down syndrome screening: free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

First-trimester and early second-trimester diagnosis of nuchal cystic hygroma by transvaginal sonography: diverse prognosis of the septated from the nonseptated lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Chorionic villus sampling after first trimester diagnosis of fetal cystic hygroma colli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Diagnosis and significance of cystic hygroma in the first trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Down's syndrome screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Down's syndrome screening in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Repeatability of measurement of fetal nuchal translucency thickness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Randomised comparison of amniocentesis and transabdominal and transcervical chorionic villus sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Randomised controlled trial of genetic amniocentesis in 4606 low-risk women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Appraisal of a new scheme for prenatal screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

When marginal costs and benefits should be used in screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Using decision analysis to compare policies for antenatal screening for Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Six weeks to twenty-one years old: a longitudinal study of children with Down's syndrome and their families. Third Jack Tizard memorial lecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Early mortality and morbidity in children with Down's syndrome diagnosed in two regional health authorities in 1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Abnormalities of thyroid function in infants with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Anxiety in women with low maternal serum alpha-fetoprotein screening results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Low level of maternal serum α-fetoprotein: Its associated anxiety and the effects of genetic counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Serum screening for Down's syndrome: some women's experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Women's opinions on the offer and use of maternal serum screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Is routine AFP screening in pregnancy reassuring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

A randomised trial of three methods of giving information about prenatal testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Serum screening for Down's syndrome: experiences of obstetricians in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Maternal serum screening for Down syndrome in the United States: a 1995 survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

Presenting a routine screening test in antenatal care: Practice observed

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096914139700400402

10.1177/096914139700400402

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9494915